The Hidden Danger of Ozempic for People with Glaucoma: What You Need to Know
Please hit the ❤️ at the top or bottom of this email to help others discover All About Vision With Dr. Kondrot. Your subscription directly supports my ongoing humanitarian work—delivering free eye surgeries and care where it's needed most.
Story at a Glance
Ozempic (semaglutide)—a GLP‑1 receptor agonist used for type 2 diabetes and weight loss—has not been linked to directly causing glaucoma, but it significantly increases the risk of NAION, a rare but serious optic nerve condition that may exacerbate existing glaucoma.
Mainstream advice: Glaucoma patients considering or using Ozempic should undergo careful optic nerve monitoring, and avoid dramatic blood glucose swings.
Holistic approaches include diet, stress reduction, vascular support, and lifestyle modifications to protect optic nerve health.
Bottom line: If you have glaucoma, or are at high risk, proceed with Ozempic collaboratively, with vigilance and both medical and natural support.
Background: What the Data Shows
A major Danish cohort study found that once‑weekly semaglutide use more than doubled the risk of NAION, with a hazard ratio of ~2.19 even after adjusting for multiple risk factors in Type 2 diabetes patients
A Massachusetts Eye and Ear cohort had similarly found a high HR of 4.28 in glaucoma‑related optic neuropathy among semaglutide users
The European Medicines Agency (EMA) concluded that NAION is a very rare but real side effect, potentially affecting up to 1 in 10,000 users
Mainstream Medical Guidance
Baseline optic nerve evaluation is essential before starting Ozempic, especially in glaucoma patients.
Frequent monitoring: Watch for sudden vision changes, visual field defects, or optic disc pallor, all potential signs of NAION.
Blood sugar control should be gradual; sudden glucose drops may compromise optic nerve perfusion.
Collaborative care: Coordinate treatment with both your endocrinologist and glaucoma specialist.
Proceed mindfully: While Ozempic offers cardiovascular and metabolic benefits, glaucoma patients need a risk-aware approach.